We are live on !
Find out more
UBS Portfolio holdings
AUM
$136B
Turnover
18.95%
1-Year Est. Return
16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136B
AUM Growth
+$7.83B
(+6.1%)
Cap. Flow
+$3.56B
Cap. Flow % of AUM
Cap. Flow %
2.62%
Top 10 Holdings %
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,064
Increased
4,754
Reduced
3,910
Closed
1,116
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$387M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$346M |
| 3 |
Crown Castle
CCI
|
+$229M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$218M |
| 5 |
Toronto Dominion Bank
TD
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
APA Corp
APA
|
+$473M |
| 3 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$453M |
| 4 |
Herc Holdings
HRI
|
+$322M |
| 5 |
PETM
PETSMART INC
PETM
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.72% |
| 2 | Energy | 9.22% |
| 3 | Financials | 6.8% |
| 4 | Healthcare | 6.74% |
| 5 | Technology | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
8026
CALL
Fiserv Inc
FISV
$25.5B
| $19K | ﹤0.01% |
600
-200
| -25% | -$6.32K |
2014 Q1
2 quarters
|
|
8027
Hurco Companies Inc
HURC
$141M
| $19K | ﹤0.01% |
500
+461
| +1,182% | +$15.3K |
2013 Q2
5 quarters
|
|
8028
PUT
International Flavors & Fragrances
IFF
$23.1B
| $19K | ﹤0.01% |
200
-200
| -50% | -$20.2K |
2014 Q2
1 quarter
|
|
8029
CALL
Knowles
KN
$2.94B
| $19K | ﹤0.01% |
+700
| New | +$21.4K |
2014 Q3
0 quarters
|
|
8030
CALL
Liquidity Services
LQDT
$1.37B
| $19K | ﹤0.01% |
1,400
+1,100
| +367% | +$15.8K |
2014 Q1
2 quarters
|
|
|
MAG
8031
CALL
DELISTED
MAG Silver
MAG
| $19K | ﹤0.01% |
2,500
-4,800
| -66% | -$42.3K |
2014 Q1
2 quarters
|
|
8032
Magyar Bancorp
MGYR
$130M
| $19K | ﹤0.01% |
2,778
+940
| +51% | +$6.24K |
2013 Q2
5 quarters
|
|
8033
Meritage Homes
MTH
$4.04B
| $19K | ﹤0.01% |
1,092
-1,988
| -65% | -$39.9K |
2013 Q2
5 quarters
|
|
8034
DELISTED
Inotiv
NOTV
| $19K | ﹤0.01% |
8,438
+6,228
| +282% | +$14.5K |
2014 Q1
2 quarters
|
|
8035
PUT
Novo Nordisk
NVO
$169B
| $19K | ﹤0.01% |
800
-21,000
| -96% | -$483K |
2013 Q2
5 quarters
|
|
8036
Ocular Therapeutix
OCUL
$1.6B
| $19K | ﹤0.01% |
+1,272
| New | +$18.8K |
2014 Q3
0 quarters
|
|
8037
CALL
PetMed Express
PETS
$25.8M
| $19K | ﹤0.01% |
1,400
-2,400
| -63% | -$33.4K |
2013 Q2
5 quarters
|
|
8038
Insulet
PODD
$10.3B
| $19K | ﹤0.01% |
497
-625
| -56% | -$22.8K |
2013 Q2
5 quarters
|
|
8039
PUT
VanEck Retail ETF
RTH
$248M
| $19K | ﹤0.01% |
+300
| New | +$18.3K |
2014 Q3
0 quarters
|
|
8040
Saratoga Investment
SAR
$211M
| $19K | ﹤0.01% |
1,170
-207
| -15% | -$3.3K |
2013 Q2
5 quarters
|
|
8041
Origin Agritech
SEED
$11.1M
| $19K | ﹤0.01% |
887
-456
| -34% | -$9.6K |
2013 Q2
5 quarters
|
|
8042
ProShares Ultra Consumer Staples
UGE
$9.49M
| $19K | ﹤0.01% |
+2,664
| New | +$19.2K |
2014 Q3
0 quarters
|
|
8043
CALL
Essential Utilities
WTRG
$12B
| $19K | ﹤0.01% |
800
-500
| -38% | -$12.2K |
2013 Q2
5 quarters
|
|
8044
Tvardi Therapeutics
TVRD
$11.8M
| $19K | ﹤0.01% |
63
-164
| -72% | -$67.3K |
2014 Q2
1 quarter
|
|
8045
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| – | – |
0
| – | – |
2013 Q2
5 quarters
|
|
|
MTBL
8046
CALL
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
| $19K | ﹤0.01% |
3,733
| – | – |
2013 Q2
5 quarters
|
|
|
AMRS
8047
DELISTED
Amyris Inc.
AMRS
| $19K | ﹤0.01% |
338
+271
| +404% | +$16K |
2013 Q2
5 quarters
|
|
|
GER
8048
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
| $19K | ﹤0.01% |
+103
| New | +$18.6K |
2014 Q3
0 quarters
|
|
|
DISCK
8049
CALL
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $19K | ﹤0.01% |
+500
| New | +$20.2K |
2014 Q3
0 quarters
|
|
|
LDL
8050
PUT
DELISTED
Lydall, Inc.
LDL
| $19K | ﹤0.01% |
700
+600
| +600% | +$16.6K |
2014 Q1
2 quarters
|
|
Similar funds
MGC
UBS's Q3 2014 Portfolio in Review
As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS's Q3 2014 filing shows 1,064 new, 4,754 increased, 3,910 reduced and 1,116 closed positions. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 47% a quarter earlier, followed by Energy and Financials.
- UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
- UBS added most to Amgen in Q3 2014, an estimated $387M increase.
- UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
- UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
- UBS opened 1,064 new positions and closed 1,116 in Q3 2014.
- UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.